nach oben

Heart Failure Reviews

Erschienen in:

01.09.2009

OSA: the new cardiovascular disease

Part II: overview of cardiovascular diseases associated with obstructive sleep apnea

verfasst von: Kiran Devulapally, Raymond Pongonis Jr., Rami Khayat

Erschienen in: Heart Failure Reviews | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Obstructive sleep apnea (OSA), present in 5–15% of adults, is strongly associated with the incidence and poor outcome of hypertension, coronary artery disease, arrhythmia, heart failure, and stroke. Treatment of OSA completely reverses its cardiovascular consequences. In this review, we discuss the clinical evidence for the strong association between OSA and cardiovascular disease and present an argument for approaching OSA as a cardiovascular disease. We particularly focus on the causative relationship between OSA and hypertension, and on the increasingly recognized relationship between OSA and heart failure.

Young T et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328(17):1230–1235. doi:10.1056/NEJM199304293281704 PubMed

Center for Disease Control and Prevention. N.C.f.h.S., Health, U.D.o.H.a.H. Services, Editor (2006) National Health Interview Survey: US Census

Marin JM et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053PubMed

Peppard PE et al (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342(19):1378–1384. doi:10.1056/NEJM200005113421901 PubMed

Young T et al (1997) Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157(15):1746–1752. doi:10.1001/archinte.157.15.1746 PubMed

Wilcox I et al (1993) Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep 16(6):539–544PubMed

Becker HF et al (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107(1):68–73. doi:10.1161/01.CIR.0000042706.47107.7A PubMed

Peker Y, Carlson J, Hedner J (2006) Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 28(3):596–602. doi:10.1183/09031936.06.00107805 PubMed

Gami AS et al (2004) Association of atrial fibrillation and obstructive sleep apnea. Circulation 110(4):364–367. doi:10.1161/01.CIR.0000136587.68725.8E PubMed

10.

Kanagala R et al (2003) Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 107(20):2589–2594PubMed

11.

Reichmuth KJ et al (2005) Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 172(12):1590–1595. doi:10.1164/rccm.200504-637OC PubMed

12.

Alchanatis M et al (2002) Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J 20(5):1239–1245. doi:10.1183/09031936.02.00278002 PubMed

13.

Amin RS et al (2002) Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med 165(10):1395–1399. doi:10.1164/rccm.2105118 PubMed

14.

Wang H et al (2007) Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 49(15):1625–1631. doi:10.1016/j.jacc.2006.12.046 PubMed

15.

Kaneko Y et al (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348(13):1233–1241PubMed

16.

McNicholas WT, Bonsigore MR (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29(1):156–178. doi:10.1183/09031936.00027406 PubMed

17.

Campos-Rodriguez F et al (2005) Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 128(2):624–633. doi:10.1378/chest.128.2.624 PubMed

18.

Doherty LS et al (2005) Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 127(6):2076–2084. doi:10.1378/chest.127.6.2076 PubMed

19.

Hajjar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 290(2):199–206. doi:10.1001/jama.290.2.199 PubMed

20.

Fields LE et al (2004) The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 44(4):398–404. doi:10.1161/01.HYP.0000142248.54761.56 PubMed

21.

World Health Report 2002: Reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization, 2002. http://who.int/whr/2002

22.

Young T, Skatrud J, Peppard PE (2004) Risk factors for obstructive sleep apnea in adults. JAMA 291(16):2013–2016. doi:10.1001/jama.291.16.2013 PubMed

23.

Peker Y et al (2002) Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 166(2):159–165. doi:10.1164/rccm.2105124 PubMed

24.

Silverberg DS, Oksenberg A (2001) Are sleep-related breathing disorders important contributing factors to the production of essential hypertension? Curr Hypertens Rep 3(3):209–215. doi:10.1007/s11906-001-0040-8 PubMed

25.

Hedner J et al (2006) Hypertension prevalence in obstructive sleep apnoea and sex: a population-based case-control study. Eur Respir J 27(3):564–570. doi:10.1183/09031936.06.00042105 PubMed

26.

Lugaresi E et al (1980) Some epidemiological data on snoring and cardiocirculatory disturbances. Sleep 3(3–4):221–224PubMed

27.

Partinen M, Guilleminault C (1990) Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 97(1):27–32. doi:10.1378/chest.97.1.27 PubMed

28.

Davies CW et al (2000) Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 55(9):736–740. doi:10.1136/thorax.55.9.736 PubMed

29.

Suzuki M et al (1996) Blood pressure “dipping” and “non-dipping” in obstructive sleep apnea syndrome patients. Sleep 19(5):382–387PubMed

30.

Baguet JP et al (2005) Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 23(3):521–527. doi:10.1097/01.hjh.0000160207.58781.4e PubMed

31.

Sharabi Y et al (2003) Diastolic blood pressure is the first to rise in association with early subclinical obstructive sleep apnea: lessons from periodic examination screening. Am J Hypertens 16(3):236–239. doi:10.1016/S0895-7061(02)03250-8 PubMed

32.

Grote L, Hedner J, Peter JH (2001) Mean blood pressure, pulse pressure and grade of hypertension in untreated hypertensive patients with sleep-related breathing disorder. J Hypertens 19(4):683–690. doi:10.1097/00004872-200104000-00004 PubMed

33.

Haas DC et al (2005) Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 111(5):614–621. doi:10.1161/01.CIR.0000154540.62381.CF PubMed

34.

Sin DD et al (2003) Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. Chest 123(5):1536–1543. doi:10.1378/chest.123.5.1536 PubMed

35.

Hla KM et al (1994) Sleep apnea and hypertension. A population-based study. Ann Intern Med 120(5):382–388PubMed

36.

Nieto FJ et al (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283(14):1829–1836. doi:10.1001/jama.283.14.1829 PubMed

37.

Brooks D et al (1997) Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99(1):106–109. doi:10.1172/JCI119120 PubMed

38.

Fletcher EC (2001) Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol 90(4):1600–1605PubMed

39.

Fletcher EC (2000) Cardiovascular consequences of obstructive sleep apnea: experimental hypoxia and sympathetic activity. Sleep 23(Suppl 4):S127–S131PubMed

40.

Bao G et al (1997) Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol 83(1):95–101PubMed

41.

Fletcher EC, Bao G (1996) The rat as a model of chronic recurrent episodic hypoxia and effect upon systemic blood pressure. Sleep 19(10, Suppl):S210–S212PubMed

42.

Xie A et al (2000) Neurocirculatory consequences of intermittent asphyxia in humans. J Appl Physiol 89(4):1333–1339PubMed

43.

Khayat RN et al (2003) Cardiorespiratory effects of added dead space in patients with heart failure and central sleep apnea. Chest 123(5):1551–1560. doi:10.1378/chest.123.5.1551 PubMed

44.

Katragadda S et al (1997) Neural mechanism of the pressor response to obstructive and nonobstructive apnea. J Appl Physiol 83(6):2048–2054PubMed

45.

Arabi Y et al (1999) Daytime blood pressure elevation after nocturnal hypoxia. J Appl Physiol 87(2):689–698PubMed

46.

Logan AG et al (2001) High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19(12):2271–2277. doi:10.1097/00004872-200112000-00022 PubMed

47.

MacMahon S et al (1990) Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335(8692):765–774. doi:10.1016/0140-6736(90)90878-9 PubMed

48.

Pepperell JC et al (2002) Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359(9302):204–210. doi:10.1016/S0140-6736(02)07445-7 PubMed

49.

Campos-Rodriguez F et al (2007) Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea. Chest 132(6):1847–1852. doi:10.1378/chest.07-1478 PubMed

50.

Robinson GV et al (2006) Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 27(6):1229–1235. doi:10.1183/09031936.06.00062805 PubMed

51.

Somers VK et al (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96(4):1897–1904. doi:10.1172/JCI118235 PubMed

52.

Adhikary G et al (2001) Gene regulation during intermittent hypoxia: evidence for the involvement of reactive oxygen species. Adv Exp Med Biol 499:297–302PubMed

53.

Prabhakar NR et al (2001) Intermittent hypoxia: cell to system. Am J Physiol Lung Cell Mol Physiol 281(3):L524–L528PubMed

54.

Xie A et al (2001) Exposure to hypoxia produces long-lasting sympathetic activation in humans. J Appl Physiol 91(4):1555–1562PubMed

55.

Fletcher EC (1997) Sympathetic activity and blood pressure in the sleep apnea syndrome. Respiration 64(Suppl 1):22–28PubMed

56.

Lavie L, Vishnevsky A, Lavie P (2004) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27(1):123–128PubMed

57.

Carpagnano GE et al (2003) 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124(4):1386–1392. doi:10.1378/chest.124.4.1386 PubMed

58.

Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115(10):1285–1295PubMed

59.

Prior JO et al (2005) Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation 111(18):2291–2298. doi:10.1161/01.CIR.0000164232.62768.51 PubMed

60.

Bugiardini R et al (2004) Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 109(21):2518–2523. doi:10.1161/01.CIR.0000128208.22378.E3 PubMed

61.

De Vriese AS et al (2004) Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia. Circulation 109(19):2331–2336. doi:10.1161/01.CIR.0000129138.08493.4D PubMed

62.

MacCarthy PA, Shah AM (2000) Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy. Circulation 101(15):1854–1860PubMed

63.

Grebe M et al (2006) Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 173(8):897–901. doi:10.1164/rccm.200508-1223OC PubMed

64.

Bostrom KB et al (2007) Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension. J Hypertens 25(4):779–783PubMed

65.

Moller DS et al (2003) Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 16(4):274–280. doi:10.1016/S0895-7061(02)03267-3 PubMed

66.

Fletcher EC, Orolinova N, Bader M (2002) Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 92(2):627–633PubMed

67.

Fletcher EC, Bao G, Li R (1999) Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 34(2):309–314PubMed

68.

Rosamond W et al (2007) Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115(5):e69–e171. doi:10.1161/CIRCULATIONAHA.106.179918 PubMed

69.

Nieminen MS et al (2006) EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27(22):2725–2736. doi:10.1093/eurheartj/ehl193 PubMed

70.

Ip MS et al (2004) Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169(3):348–353. doi:10.1164/rccm.200306-767OC PubMed

71.

Schulz R et al (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162(2 Pt 1):566–570PubMed

72.

Barcelo A et al (2000) Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 16(4):644–647. doi:10.1034/j.1399-3003.2000.16d13.x PubMed

73.

Minoguchi K et al (2005) Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172(5):625–630. doi:10.1164/rccm.200412-1652OC PubMed

74.

Sorajja D et al (2008) Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest 133(4):927–933PubMed

75.

Hanly P et al (1993) ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 71(15):1341–1345. doi:10.1016/0002-9149(93)90552-N PubMed

76.

Alonso-Fernandez A et al (2005) Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep apnea-hypopnea syndrome and its mechanisms. Chest 127(1):15–22. doi:10.1378/chest.127.1.15 PubMed

77.

Peled N et al (1999) Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol 34(6):1744–1749. doi:10.1016/S0735-1097(99)00407-6 PubMed

78.

Peters RW (2005) Obstructive sleep apnea and cardiovascular disease. Chest 127(1):1–3. doi:10.1378/chest.127.1.1 PubMed

79.

Schafer H et al (1997) Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest 111(2):387–393. doi:10.1378/chest.111.2.387 PubMed

80.

Beguin PC et al (2005) Acute intermittent hypoxia improves rat myocardium tolerance to ischemia. J Appl Physiol 99(3):1064–1069. doi:10.1152/japplphysiol.00056.2005 PubMed

81.

Joyeux-Faure M et al (2005) Chronic intermittent hypoxia increases infarction in the isolated rat heart. J Appl Physiol 98(5):1691–1696. doi:10.1152/japplphysiol.01146.2004 PubMed

82.

Shahar E et al (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163(1):19–25PubMed

83.

Peker Y et al (2000) Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162(1):81–86PubMed

84.

Mooe T et al (2001) Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 164(10 Pt 1):1910–1913PubMed

85.

Yumino D et al (2007) Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 99(1):26–30. doi:10.1016/j.amjcard.2006.07.055 PubMed

86.

Milleron O et al (2004) Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 25(9):728–734. doi:10.1016/j.ehj.2004.02.008 PubMed

87.

Javaheri S (2000) Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 101(4):392–397PubMed

88.

Mehra R et al (2006) Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 173(8):910–916. doi:10.1164/rccm.200509-1442OC PubMed

89.

Ryan CM et al (2005) Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 60(9):781–785. doi:10.1136/thx.2005.040972 PubMed

90.

Gilman MP et al (2008) Continuous positive airway pressure increases heart rate variability in heart failure patients with obstructive sleep apnoea. Clin Sci (Lond) 114(3):243–249. doi:10.1042/CS20070172 CrossRef

91.

Gami AS et al (2007) Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49(5):565–571. doi:10.1016/j.jacc.2006.08.060 PubMed

92.

Gami AS et al (2005) Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 352(12):1206–1214. doi:10.1056/NEJMoa041832 PubMed

93.

Yaggi HK et al (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353(19):2034–2041. doi:10.1056/NEJMoa043104 PubMed

94.

Mehra R, Benjamin EJ, Shahar E et al (2006) Association of nocturnal arrhythmias with sleep-disordered breathing: the sleep heart health study. Am J Respir Crit Care Med 173(8):910–916PubMed

95.

Ferrier K et al (2005) Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 128(4):2116–2122. doi:10.1378/chest.128.4.2116 PubMed

96.

Javaheri S (2006) Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 106(1):21–28. doi:10.1016/j.ijcard.2004.12.068 PubMed

97.

Javaheri S et al (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97(21):2154–2159PubMed

98.

Mossey P, Singh GD, Smith ME (1999) More extensive analysis is needed when assessing facial structure in SIDS. BMJ (Clin Res Ed.) 318(7180):396–397

99.

Sin DD et al (1999) Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160(4):1101–1106PubMed

100.

Hedner J, Ejnell H, Caidahl K (1990) Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens 8(10):941–946. doi:10.1097/00004872-199010000-00009 PubMed

101.

Laaban JP et al (2002) Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest 122(4):1133–1138. doi:10.1378/chest.122.4.1133 PubMed

102.

Parker JD et al (1999) Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med 160(6):1888–1896PubMed

103.

Tkacova R et al (1998) Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 98(21):2269–2275PubMed

104.

Chen L, Shi Q, Scharf SM (2000) Hemodynamic effects of periodic obstructive apneas in sedated pigs with congestive heart failure. J Appl Physiol 88(3):1051–1060PubMed

105.

Scharf SM, Graver LM, Balaban K (1992) Cardiovascular effects of periodic occlusions of the upper airways in dogs. Am Rev Respir Dis 146(2):321–329PubMed

106.

Chen L, Scharf SM (1998) Systemic and myocardial hemodynamics during periodic obstructive apneas in sedated pigs. J Appl Physiol 84(4):1289–1298PubMed

107.

Spaak J et al (2005) Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension 46(6):1327–1332. doi:10.1161/01.HYP.0000193497.45200.66 PubMed

108.

Usui K et al (2005) Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 45(12):2008–2011. doi:10.1016/j.jacc.2004.12.080 PubMed

109.

Malone S et al (1991) Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 338(8781):1480–1484. doi:10.1016/0140-6736(91)92299-H PubMed

110.

Mansfield DR, Naughton MT (2004) Sleep apnea and congestive heart failure. Minerva Med 95(4):257–280PubMed

111.

Roebuck T et al (2004) Increased long-term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J 23(5):735–740. doi:10.1183/09031936.04.00060404 PubMed

112.

Bady E et al (2000) Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax 55(11):934–939. doi:10.1136/thorax.55.11.934 PubMed

113.

Sajkov D et al (1994) Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 149(2 Pt 1):416–422PubMed

114.

Sanner BM et al (1997) Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med 157(21):2483–2487. doi:10.1001/archinte.157.21.2483 PubMed

115.

Chaouat A et al (1996) Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 109(2):380–386. doi:10.1378/chest.109.2.380 PubMed

116.

Weitzenblum E et al (1988) Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 138(2):345–349PubMed

117.

Atwood CW Jr et al (2004) Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):72S–77S. doi:10.1378/chest.126.1_suppl.72S PubMed

118.

Gozal D, Lipton AJ, Jones KL (2002) Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 25(1):59–65PubMed

119.

Lavie L et al (2002) Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165(12):1624–1628. doi:10.1164/rccm.20110-040OC PubMed

120.

Berman EJ et al (1991) Right ventricular hypertrophy detected by echocardiography in patients with newly diagnosed obstructive sleep apnea. Chest 100(2):347–350. doi:10.1378/chest.100.2.347 PubMed

121.

Sanner BM et al (1997) Right ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J 10(9):2079–2083. doi:10.1183/09031936.97.10092079 PubMed

122.

Nahmias J, Lao R, Karetzky M (1996) Right ventricular dysfunction in obstructive sleep apnoea: reversal with nasal continuous positive airway pressure. Eur Respir J 9(5):945–951. doi:10.1183/09031936.96.09050945 PubMed

123.

Alchanatis M et al (2001) Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics. Respiration 68(6):566–572. doi:10.1159/000050574 PubMed

124.

Sajkov D et al (2002) Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 165(2):152–158PubMed

125.

Bassetti CL, Milanova M, Gugger M (2006) Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke 37(4):967–972. doi:10.1161/01.STR.0000208215.49243.c3 PubMed

126.

Foster GE et al (2007) Effects of continuous positive airway pressure on cerebral vascular response to hypoxia in patients with obstructive sleep apnea. Am J Respir Crit Care Med 175(7):720–725. doi:10.1164/rccm.200609-1271OC PubMed

127.

Phillips SA et al (2004) Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 286(1):H388–H393. doi:10.1152/ajpheart.00683.2003 PubMed

128.

Baguet JP et al (2005) The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 128(5):3407–3412. doi:10.1378/chest.128.5.3407 PubMed

129.

Suzuki T et al (2004) Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep 27(1):129–133PubMed

130.

Drager LF et al (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176(7):706–712. doi:10.1164/rccm.200703-500OC PubMed

131.

Yaggi H, Mohsenin V (2004) Obstructive sleep apnoea and stroke. Lancet Neurol 3(6):333–342. doi:10.1016/S1474-4422(04)00766-5 PubMed

132.

Turkington PM, Elliott MW (2004) Sleep disordered breathing following stroke. Monaldi Arch Chest Dis 61(3):157–161PubMed

133.

Parra O et al (2000) Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 161(2 Pt 1):375–380PubMed

134.

Selic C et al (2005) Blood pressure evolution after acute ischemic stroke in patients with and without sleep apnea. Stroke 36(12):2614–2618. doi:10.1161/01.STR.0000189689.65734.a3 PubMed

135.

Parra O et al (2004) Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur Respir J 24(2):267–272. doi:10.1183/09031936.04.00061503 PubMed

136.

Martinez-Garcia MA et al (2005) Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest 128(4):2123–2129. doi:10.1378/chest.128.4.2123 PubMed

137.

Dziewas R et al (2005) Increased prevalence of sleep apnea in patients with recurring ischemic stroke compared with first stroke victims. J Neurol 252(11):1394–1398. doi:10.1007/s00415-005-0888-7 PubMed

138.

Kaneko Y et al (2003) Relationship of sleep apnea to functional capacity and length of hospitalization following stroke. Sleep 26(3):293–297PubMed

139.

Arzt M et al (2005) Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 172(11):1447–1451. doi:10.1164/rccm.200505-702OC PubMed

140.

Good DC et al (1996) Sleep-disordered breathing and poor functional outcome after stroke. Stroke 27(2):252–259PubMed

Titel: OSA: the new cardiovascular disease
Part II: overview of cardiovascular diseases associated with obstructive sleep apnea
verfasst von: Kiran Devulapally
Raymond Pongonis Jr.
Rami Khayat
Publikationsdatum: 01.09.2009
Verlag: Springer US
Erschienen in: Heart Failure Reviews / Ausgabe 3/2009
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-008-9101-2

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

OSA: the new cardiovascular disease

Part II: overview of cardiovascular diseases associated with obstructive sleep apnea

Abstract

Neu im Fachgebiet Kardiologie

Schadet Ärger den Gefäßen?

Intervallfasten zur Regeneration des Herzmuskels?

Shunt-Therapie bei Herzinsuffizienz: Kein Anzug, der allen passt

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Update Kardiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2009

Sleep-disordered breathing in patients with decompensated heart failure

Obstructive sleep apnea: the new cardiovascular disease. Part I: obstructive sleep apnea and the pathogenesis of vascular disease

Central sleep apnea in patients with congestive heart failure

Insomnia and chronic heart failure

An integrated approach to managing sleep disordered breathing and cardiovascular disease

Treatment of sleep disordered breathing in congestive heart failure

Neu im Fachgebiet Kardiologie

Schadet Ärger den Gefäßen?

Intervallfasten zur Regeneration des Herzmuskels?

Shunt-Therapie bei Herzinsuffizienz: Kein Anzug, der allen passt

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Update Kardiologie